Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume $0.03 +0.00 (+0.29%) As of 07/3/2025 12:13 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Short Interest DataPetros Pharmaceuticals (PTPI) has a short interest of 403,300 shares, representing 4.06% of the float (the number of shares available for trading by the public). This marks a -11.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 3.15 million shares to cover all short positions.Current Short Interest403,300 sharesPrevious Short Interest456,800 sharesChange Vs. Previous Month-11.71%Dollar Volume Sold Short$12.50 thousandShort Interest Ratio0.3 Days to CoverLast Record DateJune 15, 2025Outstanding Shares31,160,000 sharesShort Percent of Float4.06%Today's Trading Volume245,089 sharesAverage Trading Volume3,147,408 sharesToday's Volume Vs. Average8% Short Selling Petros Pharmaceuticals? Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTPI Short Interest Over TimePTPI Days to Cover Over TimePTPI Percentage of Float Shorted Over Time Petros Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025403,300 shares $12.50 thousand -11.7%4.1%0.3 $0.03 5/31/2025456,800 shares $15.12 thousand +91.9%4.6%0 $0.03 5/15/2025238,100 shares $38.10 thousand -51.8%2.4%0 $0.16 4/30/2025493,800 shares $148.14 thousand -83.5%28.2%0.1 $0.30 4/15/20253,000,000 shares $138 thousand +102.7%30.2%0.1 $0.05 3/31/20251,480,000 shares $102.27 thousand +98.6%14.9%0 $0.07 3/15/2025745,300 shares $62.90 thousand +113.1%7.5%0.1 $0.08 2/28/2025349,800 shares $34.21 thousand -83.3%3.5%0.1 $0.10 2/15/20252,100,000 shares $615.30 thousand +187.3%21.1%0.4 $0.29 1/31/2025731,000 shares $204.46 thousand +15.7%N/A0.4 $0.28 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025631,800 shares $189.54 thousand -2.2%6.9%0.3 $0.30 12/31/2024646,200 shares $254.54 thousand +139.6%7.1%0.3 $0.39 12/15/2024269,700 shares $88.95 thousand +48.9%3.0%0.2 $0.33 11/30/2024181,100 shares $49.69 thousand -9.7%2.0%0.9 $0.27 11/15/2024200,600 shares $51.96 thousand +0.7%2.2%1.1 $0.26 10/31/2024199,200 shares $73.70 thousand -27.2%2.2%1.2 $0.37 10/15/2024273,600 shares $83.39 thousand -7.2%3.1%1.4 $0.30 9/30/2024294,900 shares $105.28 thousand +25.4%3.4%1.3 $0.36 9/15/2024235,100 shares $85.65 thousand -20.6%2.7%0.8 $0.36 8/31/2024295,900 shares $98.45 thousand +13.5%3.5%0.8 $0.33 8/15/2024260,700 shares $86.97 thousand -40.0%3.1%0.6 $0.33 7/31/2024434,200 shares $176.29 thousand +69.9%7.1%1 $0.41 7/15/2024255,500 shares $116.00 thousand -28.5%4.2%0.6 $0.45 6/30/2024357,200 shares $163.42 thousand -23.7%5.8%1 $0.46 6/15/2024468,300 shares $194.58 thousand +202.3%7.7%1 $0.42 5/31/2024154,900 shares $95.14 thousand +82.9%2.5%0.3 $0.61 5/15/202484,700 shares $43.67 thousand -37.0%1.4%0.1 $0.52 4/30/2024134,500 shares $88.30 thousand +92.7%3.3%0.2 $0.66 4/15/202469,800 shares $54.66 thousand -52.3%1.7%0.1 $0.78 3/31/2024146,200 shares $216.38 thousand +65.4%3.6%0.1 $1.48 3/15/202488,400 shares $134.37 thousand -72.1%6.8%0.1 $1.52 2/29/2024317,200 shares $545.58 thousand +12.3%24.2%0.3 $1.72 2/15/2024282,400 shares $434.90 thousand +16.5%21.9%0.3 $1.54 1/31/2024242,400 shares $293.30 thousand +2,208.6%18.8%0.4 $1.21 1/15/202410,500 shares $13.81 thousand -74.8%0.8%0 $1.32 12/31/202341,700 shares $58.80 thousand -66.5%3.1%0.2 $1.41 12/15/2023124,300 shares $172.78 thousand +571.9%9.1%0.6 $1.39 11/30/202318,500 shares $29.60 thousand -28.3%1.4%0.2 $1.60 11/15/202325,800 shares $34.31 thousand -41.6%2.0%0.8 $1.33 10/31/202344,200 shares $63.21 thousand -27.9%3.5%1.3 $1.43The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 10/15/202361,300 shares $98.07 thousand +415.1%4.9%1.4 $1.60 9/30/202311,900 shares $20.59 thousand +213.2%0.9%0 $1.73 9/15/20233,800 shares $6.88 thousand -82.3%0.3%0 $1.81 8/31/202321,500 shares $54.83 thousand -62.7%1.7%0.1 $2.55 8/15/202357,700 shares $184.64 thousand -21.9%3.9%0.2 $3.20 7/31/202373,900 shares $296.34 thousand -79.4%5.0%0.2 $4.01 7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19 6/30/202325,100 shares $50.95 thousand -27.0%1.7%0 $2.03 6/15/202334,400 shares $89.78 thousand -10.7%2.3%0 $2.61 5/31/202338,500 shares $89.71 thousand -13.5%2.6%0 $2.33 5/15/202344,500 shares $186.90 thousand -88.5%3.0%0 $4.20 4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30 4/15/202334,100 shares $156.52 thousand -22.5%2.4%0 $4.59 3/31/202344,000 shares $61.38 thousand +14.9%3.1%3.1 $1.40 3/15/202338,300 shares $56.68 thousand +13.0%2.7%2.1 $1.48 2/28/202333,900 shares $71.19 thousand -6.6%2.4%1.6 $2.10 2/15/202336,300 shares $92.20 thousand +23.1%2.5%1.8 $2.54 1/31/202329,500 shares $76.70 thousand -24.4%2.1%1.5 $2.60 1/15/202339,000 shares $118.95 thousand +14.0%2.7%1.6 $3.05 12/30/202234,200 shares $79.69 thousand +14.8%2.4%1.4 $2.33 12/15/202229,800 shares $63.18 thousand +43.3%2.1%1.8 $2.12 11/30/202220,800 shares $8.55 thousand -92.2%1.4%1.5 $0.41 11/15/2022265,700 shares $130.19 thousand +78.6%N/A2.1 $0.49 10/31/2022148,800 shares $71.42 thousand +9.3%N/A1 $0.48 10/15/2022136,200 shares $58.53 thousand +77.3%N/A0.2 $0.43 9/30/202276,800 shares $39.17 thousand -36.1%N/A0.1 $0.51 9/15/2022120,200 shares $78.68 thousand -7.1%N/A0.1 $0.65 8/31/2022129,400 shares $84.82 thousand +45.4%N/A0.1 $0.66 8/15/202289,000 shares $71.63 thousand +420.5%N/A0.1 $0.80 7/31/202217,100 shares $13.57 thousand -22.3%N/A0 $0.79 7/15/202222,000 shares $18.10 thousand -56.2%N/A0.1 $0.82 6/30/202250,200 shares $42.16 thousand +46.8%N/A0 $0.84 6/15/202234,200 shares $26.74 thousand -81.0%N/A0 $0.78 5/31/2022179,500 shares $174.98 thousand +89.2%N/A0.1 $0.97 5/15/202294,900 shares $91.11 thousand -30.0%N/A0.1 $0.96 4/30/2022135,600 shares $153.23 thousand -26.0%N/A0.1 $1.13 4/15/2022183,300 shares $221.79 thousand -39.8%N/A0.1 $1.21 3/31/2022304,400 shares $474.86 thousand +15.1%N/A0.4 $1.56 3/15/2022264,500 shares $285.66 thousand -39.7%N/A0.1 $1.08 2/28/2022438,900 shares $605.68 thousand -38.5%N/A0.1 $1.38 2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59 1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73 1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62 12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33 12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87 11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86 11/15/2021382,400 shares $833.63 thousand +359.6%8.9%0.1 $2.18 10/29/202183,200 shares $144.77 thousand -22.2%2.6%0 $1.74 10/15/2021106,900 shares $175.32 thousand +20.0%1.8%1.2 $1.64 9/30/202189,100 shares $178.20 thousand -22.9%1.5%1.6 $2.00This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin 9/15/2021115,600 shares $239.29 thousand -20.8%1.9%2.1 $2.07 8/31/2021145,900 shares $328.28 thousand -16.1%2.4%1.8 $2.25 8/13/2021173,900 shares $525.18 thousand -9.1%2.8%1.7 $3.02 7/30/2021191,200 shares $581.25 thousand +19.3%3.1%0.9 $3.04 7/15/2021160,300 shares $488.92 thousand +18.3%2.6%0.8 $3.05 6/30/2021135,500 shares $424.12 thousand +21.1%2.2%0.7 $3.13 6/15/2021111,900 shares $349.13 thousand +105.0%1.8%0.5 $3.12 5/28/202154,600 shares $165.44 thousand -1.1%0.9%0.3 $3.03 5/14/202155,200 shares $162.84 thousand -18.9%0.9%0.3 $2.95 4/30/202168,100 shares $224.73 thousand +6.2%1.1%1.4 $3.30 4/15/202164,100 shares $201.92 thousand -19.0%1.0%0.8 $3.15 3/31/202179,100 shares $288.72 thousand +4.2%1.3%0.9 $3.65 3/15/202175,900 shares $256.54 thousand +20.5%1.2%0.5 $3.38 2/26/202163,000 shares $218.61 thousand -9.1%1.0%0.4 $3.47 2/12/202169,300 shares $293.83 thousand +234.8%1.1%0.4 $4.24 1/29/202120,700 shares $70.17 thousand +269.6%0.3%0.1 $3.39 1/15/20215,600 shares $24.14 thousand No ChangeN/A0 $4.31 PTPI Short Interest - Frequently Asked Questions What is Petros Pharmaceuticals' current short interest? Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 403,300 shares of PTPI short. 4.06% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest. What is a good short interest percentage for Petros Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.06% of Petros Pharmaceuticals' floating shares are currently sold short. Is Petros Pharmaceuticals' short interest increasing or decreasing? Petros Pharmaceuticals saw a drop in short interest in June. As of June 15th, there was short interest totaling 403,300 shares, a drop of 11.7% from the previous total of 456,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Petros Pharmaceuticals' short interest compare to its competitors? 4.06% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: InMed Pharmaceuticals Inc. (2.76%), Titan Pharmaceuticals, Inc. (1.84%), Evoke Pharma, Inc. (1.26%), Lipella Pharmaceuticals Inc. (2.01%), Dermata Therapeutics, Inc. (1.36%), Clearmind Medicine Inc. (4.21%), Can-Fite BioPharma Ltd. (0.82%), Artelo Biosciences, Inc. (2.18%), CERo Therapeutics Holdings, Inc. (10.46%), Sonnet BioTherapeutics Holdings, Inc. (1.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Petros Pharmaceuticals stock? Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Petros Pharmaceuticals? A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further. How often is Petros Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies InMed Pharmaceuticals Short Squeeze Titan Pharmaceuticals Short Squeeze Evoke Pharma Short Squeeze Lipella Pharmaceuticals Short Squeeze Dermata Therapeutics Short Squeeze Clearmind Medicine Short Squeeze Can-Fite BioPharma Short Squeeze Artelo Biosciences Short Squeeze CERo Therapeutics Short Squeeze Sonnet BioTherapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTPI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
